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Abstract
Aims—To determine (1) the prevalence of SubD states among adults with diabetes, and (2) 
whether evidence exists of an independent association between diabetes status and SubD, 
controlling for selected confounders.
Methods—Data from the 2007–2012 National Health and Nutrition Examination Surveys were 
combined to estimates of depressive states by diabetes status among the noninstitutionalized U.S. 
adult population, and to assess the association of diabetes status and depressive states using a 
polytomous logistic regression model.
Results—An estimated 17%, or 3.7 million, of U.S. adults with diabetes (diagnosed and 
undiagnosed) met criteria for either mD or ssD. The majority of SubD cases with diabetes were 
found to be ssD (10.1%) compared with mD (6.9%). After controlling for the effects of age, sex, 
race and ethnicity, education, body mass index, and poverty as covariates, an independent 
association persists between diagnosed diabetes and each SubD grouping (ssD: OR = 1.82, CIs 
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1.33, 2.47; mD: OR = 1.95, CIs 1.39, 2.74) compared with respondents having no diabetes. No 
association was found between depression and undiagnosed diabetes or prediabetes compared with 
those having no diabetes.
Conclusion—Milder forms of depression such as ssD and mD are more extant than major 
depressive episodes among adults with diabetes. The odds that an adult with diagnosed diabetes 
meets the criteria for ssD or mD are higher by 80% and 95%, respectively, after controlling for 
age, sex, race and ethnicity, education, body mass index, and poverty factors when compared 
against adults with no diabetes.
Keywords
Subthreshold depression; Diabetes; Adults; NHANES; Subsyndromal depression; Minor 
depression
1. Introduction
Diabetes has been linked with depression in a series of cross-sectional [1–3], observational 
cohort studies [4–6], and the association has been acknowledged in systematic reviews and 
meta-analysis [7–11]. Those with diabetes are at higher risk for depression [11], and those 
with depression are at higher risk of developing diabetes relative to those with no depression 
[12]. However, a direct association does not appear when confounding factors are taken into 
consideration, according to some studies [5,13]. The interdependence of depressive states 
and diabetes is generally understood to worsen the conditions’ comorbidity. This creates a 
challenge for both primary doctors encountering such cases in their practice [14,15], and for 
public health because a certain degree of comorbidity is expected among the general 
population [14].
Studies have long shown recognition of the interdependence between unipolar major 
depressive episodes (MDE) and diabetes. For example, Li et al. [3], using data from the 
Behavioral Risk Factor Surveillance System, estimates that in the United States (U.S.), the 
prevalence of MDE among adults with diabetes is approximately 8% of the adult population. 
In a clinical setting study, Ludmant et al. [16] found the MDE–diabetes symptom association 
to be stronger than the association of diabetes symptoms with measures of glycemic control. 
Overall, such findings prevail in systematic reviews regarding the association of diabetes and 
depression [8,9,11]. A thorough review of the scientific literature in other countries reveals 
the work being done on the association between diabetes and milder forms of depressive 
states that do not fulfill the criteria for MDE, known collectively as subthreshold depressive 
states (SubD). Using data from the German National Health Interview and Examination, 
Kruse et al. [1] found that dysthymia, amild-to-moderate form of depression which lingers 
for an extended period of time, is the most prevalent affective disorder among German adults 
with diabetes. In Spain, Campayo et al. [17] examined data from a community sample of 
adults to study whether clinically significant depression is associated with the risk of 
diabetes.
While our understanding of the interdependence of MDE and diabetes at the population 
level in the U.S. has improved, little attention has been given to the examination of milder 
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forms of depression [12,13]. The paucity of research is occurring despite the American 
Diabetes Association standards recognize the benefit of early management of milder forms 
of depression among persons with diabetes [15]. The limited research available does not 
provide representative estimates of the prevalence of milder forms of depression and 
diabetes among adults in the U.S.
Population-based studies already have provided an ideal platform to further extend our 
understanding of the association between diabetes and severe forms of depression [1–
6,12,18–20]. Therefore, an analytical examination of a population-based data set to consider 
the association of diabetes and specifically SubD may prove equally worthwhile. To the best 
of our knowledge, none of the current U.S. research efforts have been comprehensive 
enough to explicitly examine SubD status among adults by diabetes states and to generalize 
the results to the larger population. Past work on depression and diabetes in the U.S. has 
provided some national prevalence estimates [3,20]. However, these estimates have been 
limited in their scope due to (a) omission of the clinical SubD criteria along with the 
recognition of MDE, (b) absence of the full ambit of diabetes status, (c) data collection bias 
[3], and (d) use of clinical samples that limit generalization [20]. Thus, the empirical 
identification of milder forms of depressive states among the general adult population by 
diabetes status remains an important topic for research. The aim of this study is to address 
this gap by examining (1) whether evidence exists of an independent association between 
subD states and diabetes among the adult population, and (2) whether the proposed 
association persists after adjustment for selected covariates. For a better understanding of the 
current public health burden, weighted prevalence and population counts of depressive states 
by diabetes status based on the 2007–2012 U.S. noninstitutionalized adult population are 
also presented.
2. Materials and methods
2.1. Study design
2.1.1. Data source—The National Health and Nutrition Examination Survey (NHANES) 
is a multipurpose cross-sectional health survey that measures the health and nutritional status 
of the U.S. civilian noninstitutionalized household population. NHANES uses a stratified, 
multistage probability cluster design to select a representative sample of the population. The 
uniqueness of NHANES rests in its collection protocol, in which the standardized collection 
of self-reported health information along with clinical physical examination and laboratory 
data allows the identification of both diagnosed and undiagnosed conditions [21]. On the 
other hand, one relevant restraint of the NHANES cross-sectional survey design is that 
causality cannot be inferred.
NHANES data collection is completed in two phases. The first phase is a face-to-face 
interview in the participant’s household. The second phase consists of a series of private 
interviews, and physical and laboratory examinations held in a mobile examination center 
(MEC). Both the household and MEC interviews are performed using a standardized 
protocol with trained staff and recorded using computer-assisted personal interviewing 
(CAPI). NHANES data collection protocol has been approved by the National Center for 
Health Statistics Research Ethics Review Board. All of the participants provided written 
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informed consent. More information about NHANES collection protocols can be found 
elsewhere [22–24].
Analyses were performed using NHANES public-use data files. NHANES data files are 
based on an independent two-year cycle. For the development of an analytical study, 
NHANES guidelines recommend combining two or more cycles to increase sample size, 
subsequently increasing the statistical power, generalizability, and precision of the 
subdomain of interest [23]. Following this strategy, three NHANES data cycles were merged 
for this study (i.e., 2007–2008, 2009–2010, and 2011–2012). However, before the data were 
merged, we examined the weighted prevalence of depression and diabetes by each NHANES 
cycle separately. The prevalence of both conditions presented slight differences across 
survey cycles. However, such variability was found to be within the expected range of 
possible variations due to sampling and does not directly affect the final estimates (results 
not shown).
2.1.2. Sampling weights—To ensure that statistical estimates of desired parameters 
would be nationally representative of the subpopulation of interest (i.e., adults ages 20 years 
and older who have diabetes and depression), self-reported diabetes and fasting sampling 
weights computed by the National Center for Health Statistics (NCHS) were incorporated by 
(1) following NHANES guidelines [23,24], and (2) integrating preceding strategies used in 
analytical NHANES studies for diabetes data [25,26]. To calculate nationally representative 
estimates, the sampling weights were adjusted so that estimates would represent the full 6- 
year time period, instead of 2- or 4-year periods.
2.2. Measures
2.2.1. Outcome measure—The outcome measure was determined using the Personal 
Health Questionnaire (PHQ–9) [27]. PHQ–9 is a dual-purpose instrument for screening, 
diagnosing, monitoring, and measuring the severity of depression [28] that can be scored in 
two ways: by applying the Diagnostic and Statistical Manual of Mental Disorders, fourth 
edition (DSM–IV–TR) criteria algorithm to derive a provisional clinical diagnosis, or by 
calculating a summed score of the nine questions (ranging from 0 to 27) to establish a 
depression severity index. For this study, the DSM–IV–TR criteria-based algorithm was 
selected as the more conventional method to reflect a provisional clinical diagnosis.
PHQ-9 was administered in the MEC by trained interviewers. PHQ–9 consists of nine 
questions that ask participants to indicate how often, during the past two weeks, they had 
been affected by symptoms such as depressed mood, anhedonia, hopelessness, tiredness, 
poor appetite, moving or speaking slowly, trouble concentrating or sleeping, or suicidal 
thoughts (Supplemental Table S1). These questions are mapped to the nine depressive 
symptoms described on the DSM–IV–TR [29]. The response options for each question are, 
“Not at all” (score: 0), “Several days” (score: 1), “More than half the days” (score: 2), and 
“Nearly every day” (score: 3). Depression was indicated if the response to each PHQ-9 
question was affirmative for more than half the days (i.e., score: 2) or nearly every day (i.e., 
score: 3).
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Depressive states were divided into 4 mutually exclusive categories. A major depressive 
episode (MDE) is when a positive response is given for one of the two core symptoms of the 
DSM–IV–TR criterion A (depressed mood or loss of interest), and a total of five or more 
symptoms exist for more than half the days in the past two weeks. In addition, one of the 
nine symptom criteria—”thoughts that you would be better off dead or of hurting yourself in 
some way”—counts if present at all (i.e., score: 1, 2, or 3), regardless of duration [29,30]. 
Minor depression (mD) is defined using the provisional DSM–IV–TR research appendix 
[29]: mD is present when at least 1 core symptom (depressed mood or loss of interest) 
exists, and 2 to 4 depressive symptoms are present in the past two weeks. Subsyndromal 
symptomatic depression (ssD) is defined based on the work by Judd and colleagues [31]: 
ssD is present when 2 to 4 depressive symptoms exist in the past two weeks in survey 
respondents who do not meet criteria for either MDE or mD. Respondents who did not meet 
the criteria for MDE, mD, or ssD were listed as not having depression (reference category). 
For this study, subthreshold depressive states (SubD) include ssD and mD cases.
The PHQ–9 has extensively been used as a surveillance instrument to identify persons at risk 
of depression in a variety of settings, making it one of the most widely used tools to 
determine self-reported depressive states [32]. Analytical, as well as systematic, reviews [32] 
have documented that PHQ–9 has a sound internal consistency for use in clinical and 
nonclinical settings.
2.2.2. Main exposure—Diabetes status was based on self-reported physician diagnosis 
and MEC laboratory measures. Physician-diagnosed diabetes was obtained during the 
household interview by self-report. Identification of survey respondent may include adults 
with type 1 and type 2 diabetes. To identify persons with undiagnosed diabetes or 
prediabetes, levels of fasting plasma glucose and glycated hemoglobin (A1c) were obtained 
from participants who had a MEC examination. For these measures, the sample was limited 
to respondents who had fasted for at least 8 h but less than 24 h, and who did not report a 
previous medical diagnosis of diabetes. Definition of undiagnosed diabetes and prediabetes 
were based on American Diabetes Association guidelines [15]. Undiagnosed diabetes was 
defined based on fasting plasma glucose (FPG) of at least 126 mg/dL, or an A1c of at least 
6.5%, and no self-reported medical history of diabetes. Prediabetes was based on an FPG 
value of 100–125, or an A1c of greater than 5.7% but less than 6.5%, with no self-reported 
medical history of diabetes. Diabetes categories were mutually exclusive. Women who had 
diabetes only during pregnancy were not included in the diabetes category. In this report, 
unless otherwise specified, respondents with diabetes refers to persons with either diagnosed 
or undiagnosed diabetes.
2.2.3. Covariates—Covariate selection was performed a priori based on the existing 
scientific literature review concerning diabetes and depression. Selected covariates in this 
study include sex, age (grouped as 20–39, 40–59, and 60 and over), and race and Hispanic 
origin (non-Hispanic white, non-Hispanic black, all Hispanic, and Mexican-American). 
Poverty status was defined based on the poverty income ratio (PIR) index defined by the 
U.S. Department of Health and Human Service [33]. Three PIR categories were used: poor 
(less than 100% of the poverty level); near poor or low income (at 100% to less than 200% 
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of poverty level), and middle and high income (at 200% of poverty level or above). 
Educational attainment was defined as no high school diploma or general educational 
development (GED) equivalency; high school diploma or GED; some college but no 
bachelor’s degree; and bachelor’s degree or higher. Body mass index (BMI) was based on 
anthropometric measures collected in the MEC and calculated as weight in kilograms 
divided by height in meters squared, rounded to one decimal. BMI was defined as 
underweight (BMI < 18.4 kg/m2), healthy weight (BMI = 18.5–24.9 kg/m2), overweight 
(BMI = 25.0–29.9 kg/m2), and obese (BMI ≥ 30.0 kg/m2).
2.3. Statistical analysis
NHANES guidelines [24] were followed to calculate weighted prevalence and population 
counts. Taylor series linearization was used to compute design-based variance estimation 
represented as 95% confidence intervals (CIs). A relative standard error (RSE) of greater 
than 30% was adopted to identify unreliable statistics. All estimates shown in this report 
have an RSE less than or equal to 30%.
Bivariate and polytomous logistic regression models were used to estimate the association 
between depressive states and diabetes status. For all analyses, a cutoff p-value of less than 
0.05 was used to infer statistical significance. All statistical analyses were performed using 
Stata software and “svy commands” that accounted for the survey’s complex sample design 
(version 12, StataCorp, College Station, Texas).
2.4. Subpopulation considerations
For 2007–2012, 24,731 persons ages 20 years and older were eligible to participate in 
NHANES, 17,713 completed the interview, and 17,085 were examined, resulting in an 
overall response rate of 69.1%. For this analytical study, subgroup analysis was conducted 
on eligible adults ages 20 and older who visited the MEC and provided complete 
information on diabetes and depression (n = 7717). Responses such as “refused,” “not 
ascertained,” and “don’t know” were set to missing values.
2.5. Missing data
Multiple imputations chained equations (MICE) was implemented to address the overall 
percentage of missing data found at the selected covariates of the subgroup analysis (8% of 
the missing data belong to income, and 8% is scattered among the other covariates). 
Following MICE guidelines for the optimal overall number of imputations [34,35], we 
generated 20 complete data sets with all missing values imputed. The imputed data sets were 
then combined to produce an overall set of multiple imputation estimates for each analysis, 
reflecting both within- and between-imputation variance in the statistical estimates. More 
information on how MICE works can be found elsewhere [34,36]. To determine whether the 
results change substantially after the imputations took place, a sensitivity analysis based on 
the final version of the multiple imputations was compared with the complete-case (non-
missing data) regression model (Supplemental Table S2).
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2.6. Statistical model
2.6.1. Premodel assessment—Bivariate analyzes were performed to examine the 
association between the outcome variable and each selected covariate. The design-based 
analysis revealed that BMI was not associated with depressive status (Wald test, p = 0.39). 
However, because previous research suggested that BMI is a relevant predictor for both 
diabetes and depression in adults [38], a decision was made to keep it in the final model.
2.6.2. Interactions assessment—Before the establishment of the final model, effect 
modification was investigated by examining interactions among the covariates. Interactions 
between sex and race, and education and poverty were evident. The selected interaction 
terms were further examined individually and jointly against the final model. Further 
analysis of the interaction terms based on Wald statistics did not show a substantial change 
in the exposure-adjusted odds ratio (Supplemental Table S3). Therefore, interaction terms 
were not retained in the final model to simplify their interpretation.
2.6.3. Final model specification—The association between diabetes and depressive 
states as an outcome was examined by fitting an unadjusted and adjusted polytomous 
logistic regression model using the subgroup analysis. The adjusted odds ratio (AOR) can be 
interpreted as the main effect while controlling for the effect of the selected covariates. Data 
assumptions for the implementation of polytomous statistical models were met [36].
3. Results
3.1. SubD prevalence
During 2007–2012, an estimated 17.0% or 3.7 million of the adult population with diabetes 
(diagnosed and undiagnosed) met clinical criteria for any milder form of depressive state 
(Table 1). Among adults with diabetes, 10.1% (2.2 million) met criteria for ssD, 6.9% (1.5 
million) met criteria for mD, while 5.1% (1.1 million) met criteria for MDE.
SubD prevalence among adults with no diabetes (11.2%), undiagnosed diabetes (10.2%, p = 
0.58), and prediabetes (11.8%, p = 0.63) were comparable. However, SubD was found to be 
more prevalent among those with diagnosed diabetes (19.9%) than in another diabetes status 
under examination. Specifically, the percentage of adults with diagnosed diabetes who met 
clinical ssD criteria was higher (11.4%, or 2.5 million) than the percentage of adults with no 
diabetes and ssD (7.3%, or 1.6 million, p < 0.01), adults with undiagnosed diabetes and ssD 
(7.0%, 1.52 million, p < 0.01), or adults with prediabetes and ssD (6.2%, 1.3 million, p < 
0.01). Higher prevalence of mD was also seen among adults with diagnosed diabetes (8.5%, 
or 1.8 million) compared with adults with mD and prediabetes (5.6%, p < 0.01, 1.2 million), 
or adults having mD and no diabetes (3.9%, 0.8 million, p < 0.01).
3.2. Statistical modeling results
3.2.1. Unadjusted model—Table 2 presents results from fitting the unadjusted and 
adjusted polytomous regression models using the imputed data. Evidence from the 
unadjusted model shows an independent association between diagnosed diabetes and milder 
forms of depressive states. The odds of an adult with diagnosed diabetes having ssD is 80% 
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higher (OR = 1.80, 95% CIs 1.44, 2.25) than the odds of an adult with no diabetes (referent 
group). Adults with diagnosed have a higher odds of meeting clinical criteria for mD (OR = 
2.38; 95% CIs 1.78, 3.19) and MDE (OR = 2.81, 95% CIs 1.92, 4.11) compared to those 
without diabetes. Statistical evidence was found of an unadjusted association between MDE 
and adults with undiagnosed diabetes (OR = 1.77; 95% CIs 1.05, 2.98), and mD and 
prediabetes (OR = 1.37; 95% CIs 1.00, 1.88). No evidence of an association was found for 
undiagnosed diabetes and ssD (OR = 0.95; 95% CIs 0.61, 1.50) or mD (OR = 0.80 95% CIs 
0.47, 1.36).
3.2.2. Adjusted model—Table 2 also presents the AOR of each depressive state by 
diabetes status. After correcting for the effect of selected confounders (age, sex, race and 
ethnicity, education, BMI, and poverty), evidence of an independent association between 
adults with diagnosed diabetes and ssD remains significant (AOR = 1.82; 95% CIs 1.34, 
2.47). The AOR of adults with diabetes having mD or MDE were reduced due to the 
adjustment of the confounders but remained statistically significant (mD: AOR = 1.95; 95% 
CIs 1.39, 2.74, and MDE: AOR = 2.28; 95% CIs 1.45, 3.57). The association between MDE 
and undiagnosed diabetes (AOR = 1.42; 95% CIs 0.71, 2.84), as well as the association of 
prediabetes and mD (AOR = 1.39, 95% CIs 0.99–1.97), was partially explained when the 
effect of the preceding covariates was controlled. Consistent with the unadjusted findings 
presented in Table 2, there is evidence of no association between undiagnosed diabetes and 
ssD (OR = 0.95, 95% CIs 0.61, 1.50) or mD (OR = 0.69, 95% CIs 0.39, 1.20)
The adjusted results presented in Table 2 suggest other associations. The odds of an adult 
female fulfilling clinical criteria for each depressive state were more than 55% to 65% 
higher than the odds of a male doing so. Lower education increases the odds of mD and 
MDE being present, but not ssD. A similar trend was found with income. Adults who are 
poor or have low income have higher odds of meeting the criteria for any depressive state 
than adults who have middle or high income. The odds of adults who are poor meeting the 
criteria for ssD (AOR = 2.07; CIs 1.47, 2.90) or mD (AOR = 2.36; CIs 1.68, 3.31) were 
more than twice the odds of adults with middle or high income doing so, and more than four 
times the odds of meeting MDE criteria (AOR = 4.29; CIs 2.37, 7.80). In contrast to 
previous studies [3,5,18], this analysis did not find evidence of an association between 
depressive states and age, race and ethnicity, or BMI.
In sensitivity analysis we contrasted the imputed model (Table 2) against the complete case 
model (Supplemental Table S2) and found that the general pattern, the direction, and the 
magnitude of the AOR were generally similar (data not shown).
4. Discussion
Based on a nationally representative sample, the results of this analytical study suggest that 
milder forms of depressive states are more prevalent among adults with diagnosed diabetes 
and are independently associated with diagnosed diabetes than adults with no diabetes in the 
U.S. Regardless of age, sex, race and ethnicity, education, BMI, and poverty status, the odds 
of an adult with diagnosed diabetes meeting clinical criteria for SubD such as ssD or mD 
increased by 80% or 95%, respectively, compared to no diabetes. Consistent with earlier 
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research, sex [1,13,20], poverty [9,14,19], and low educational attainment [4,5] were found 
to be predictors of depressive states. No evidence of statistical association between milder 
forms of depressive states and undiagnosed or prediabetes compared to not having diabetes 
was found. To our knowledge, our work is the first to explicitly examine the association of 
milder forms of depressive states and the full range of diabetes status using a nationally 
representative sample.
5. Strengths and limitations
5.1. Strengths
Strengths of this study include the use of a complex survey design that allows for (1) the 
generalizability of our findings to the U.S. civilian household noninstitutionalized adult 
population, and (2) the examination of diabetes based on validated examination measures 
not confounded by treatment-seeking status [37] or selection bias (Berkson’s bias)—two 
fundamental limitations that were likely to be present in diabetes treatment sample-related 
studies. A major strength is the use of an integrated data collection system that allowed the 
identification and further statistical control of selected covariates that might cofound the 
depression effect. Another strength is the utilization of a standardized assessment protocol of 
depressive symptoms that allowed the formation of a provisional clinical diagnostic criteria 
for MDE, mD, and ssD, based on the DSM–IV–TR. Finally, the use of combined data from 
three survey cycles permitted the calculation of statistics with a high degree of precision, 
yielding stable parameters.
5.2. Limitations
This study has several limitations. One of the most salient limitations is that due to the 
NHANES cross-sectional design, we cannot rule out that the clinical manifestation of SubD 
can be perceived as either the outcome of a prodromal state, or the product of a partial 
remission of a more severe mood state such as MDE. One limitation is that the NHANES 
interview data (questionnaire) are based on self-reports, therefore, may be subject to 
misunderstanding of the question or recall problems. Another possible limitation is that we 
were not able to distinguish between adults with diabetes type 1 and type 2. However, due to 
the vast majority of work have found that type 2 diabetes is more predominant [7,26], the 
findings of this work would most likely to be representative of U.S. adults with type 2 
diabetes. Other possible limitation can be that persons with depression may not have 
participated in this survey due to the inherent limitation imposed by their emotional 
condition, in turn affecting the prevalence. And finally, NHANES results are limited to the 
U.S. civilian household noninstitutionalized adult population. Institutionalized population 
(e.g. inmates of penal or correctional facilities; long-term hospitalized population) as well as 
homeless may be more likely to present mood disorders as well of adverse health conditions.
Despite these methodological limitations, the results of our study provide the most up-to-
date estimates of the prevalence of depressive states among adults with diabetes in the U.S., 
which can be valuable for future health initiatives. The findings presented are also consistent 
with the outcomes found in another country [1,12,38],. However, distinct from previous 
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efforts, these findings expand on the concept of portraying depression beyond a dichotomous 
state and encourage the examination of depressive states as a more complex phenomenon.
6. Conclusion
In conclusion, consistent with previous research [12,17], the measured effect presented in 
this analytical study adds to the growing evidence that upholds the clinical, epidemiological, 
and scientific value of reexamining the occurrence of milder forms of depression among the 
adult population with diabetes. Information on adults with diabetes and milder forms of 
depression may prove to be valuable for implementing early disease management strategies 
that are supported by the medical care community [15] to reduce the burden and the 
reappearance of incipient forms of mood disorders such as MDE.
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